ENTEROMEDICS INC ein Zock wert??

EnteroMedics Inc. announced the preliminary results from its EMPOWER Study. Based on an initial analysis, the study did not meet its primary and secondary efficacy endpoints. There were no therapy-related serious adverse events reported in the study. The EMPOWER Study is a randomized, double-blind, placebo-controlled pivotal study designed to evaluate the safety and effectiveness of the Maestro System for the treatment of obesity.

www.reuters.com/finance/stocks/...amp;timestamp=20091002113000

October 2, 2009 3:39 PM EDT

EnteroMedics Inc., (NASDAQ: ETRM) today announced that it has entered into a definitive agreement with an institutional investor to sell 6,161,068 of the Company's common shares in a "registered direct" offering, at a price of $0.80 per share, for gross proceeds of approximately $4.9 million, before deducting placement agent fees and estimated offering expenses. Canaccord Adams Inc. acted as the sole placement agent for the offering.

The transaction is expected to close on or about October 7th, 2009, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds of this offering to fund clinical studies of VBLOC Therapy in obesity, hypertension and diabetes, as well as for general working capital purposes.

www.streetinsider.com/Equity+Offerings/...80Share/4990043.html

dass an einem Tag an dem der Kurs um fast 75% einbricht im Gegenzug gleich ein neuer Investor ein Angebot bekommt welches noch unter dem Jahrestiefststand liegt??

Hört sich alles nicht so sauber an, oder??

dass an dem gleichen Tag an dem der Kurs um fast 80% einbricht, gleich einem neuen Investor ein Angebot unterbreitet wird, welches unter dem aktuellen und zudem noch unter dem Jahrestiefststand liegt gemacht wird...


Läuft hier alles sauber??

zuerst eine Fehlermeldung und nun ist das erste Posting doch da ;-)